Literature DB >> 25209739

Complexities of medicines safety: communicating about managing medicines at transition points of care across emergency departments and medical wards.

Elizabeth Manias1, Marie Gerdtz, Allison Williams, Michael Dooley.   

Abstract

AIMS AND
OBJECTIVES: To explore how health professionals, patients and family members communicate about managing medicines across transition points of care in two Australian public hospitals.
BACKGROUND: Medicines errors are common at transition points of care. Little qualitative work has targeted communicating about medicines management across patients' journeys from admission through to discharge.
DESIGN: A qualitative descriptive study was undertaken.
METHODS: In-depth, semi-structured interviews were conducted with patients and family members, and focus groups and interviews were undertaken with doctors, nurses and pharmacists (n = 103). These individuals were situated in emergency departments and general medical wards. Data were analysed using thematic analysis.
RESULTS: Four themes were identified: contextual environment of care, competing responsibilities of care, awareness of responsibility for safety, and interprofessional communication. Contextual environment of care was affected by time pressure and efficiency, and an overriding priority to move patients out of emergency departments. In competing responsibilities of care, a reactive focus was displayed in emergency departments while a proactive stance was demonstrated in medical wards. There was an awareness of responsibility for safety, whereby key stakeholders appreciated the chain of events involved, interpersonal communication affected patients and carers, and consequences existed for patient education related to lack of information. Interdisciplinary communication was associated with communication modalities used in encounters, compartmentalised thinking, and medicines changes relayed to external providers.
CONCLUSIONS: Medicines management at transition points involved a complex interplay of dynamic features. This interplay infiltrated across diverse environments, affecting patient care within and outside hospitals. RELEVANCE TO CLINICAL PRACTICE: Health professionals require greater appreciation of each other's roles at transition points of care. Prioritisation of high-risk patients is needed, such as those with cognitive impairment and multiple co-morbidities. Establishing workable protocols of communication etiquette and a structured approach to medicines activities may assist in pre-empting problems before they occur.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  communication; family; interprofessional care; medicines management; nurses; patient; transitional care

Mesh:

Year:  2014        PMID: 25209739     DOI: 10.1111/jocn.12685

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  4 in total

Review 1.  The Role of the Nurse in the Management of Medicines During Transitional Care: A Systematic Review.

Authors:  Abbas Mardani; Pauline Griffiths; Mojtaba Vaismoradi
Journal:  J Multidiscip Healthc       Date:  2020-10-30

2.  Obstacles and Opportunities in Information Transfer Regarding Medications at Discharge - A Focus Group Study with Hospital Physicians.

Authors:  Maria Glans; Patrik Midlöv; Annika Kragh Ekstam; Åsa Bondesson; Annika Brorsson
Journal:  Drug Healthc Patient Saf       Date:  2022-05-17

3.  Interprofessional and Intraprofessional Communication about Older People's Medications across Transitions of Care.

Authors:  Elizabeth Manias; Tracey Bucknall; Robyn Woodward-Kron; Carmel Hughes; Christine Jorm; Guncag Ozavci; Kathryn Joseph
Journal:  Int J Environ Res Public Health       Date:  2021-04-08       Impact factor: 3.390

4.  Development of a tool to evaluate medication management guidance provided to carers of people living with dementia at hospital discharge: a mixed methods study.

Authors:  Mouna J Sawan; Melissa Gench; Christine Bond; Yun-Hee Jeon; Sarah N Hilmer; Timothy F Chen; Danijela Gnjidic
Journal:  BMJ Open       Date:  2022-05-02       Impact factor: 3.006

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.